Kevin Barton
  • Associate Professor
  • Hematology/Oncology
Brain Tumors, Cancers of the Blood and Blood Cells, Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Refractory Lymphoma, Relapsed Lymphoma, Amyloidosis
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high risk limited stage aggressive B-cell lymphoma: SWOG S0313Persky,D. O.; Miller,T. P.; Unger,J. M.; Spier,C. M.; Puvvada,S.; Stea,B. D.; Press,O. W.; Constine,L. S.; Barton,K. P.; Friedberg,J. W.; LeBlanc,M.; Fisher,R. I.Blood 2014 ; ( ):

Heckathorn disease revisitedNand,S.; Barton,K.; Schultz,R.; Klein,M.; Kini,A.Blood 2014 ;123(9):1429-1431

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaStiff,P. J.; Unger,J. M.; Cook,J. R.; Constine,L. S.; Couban,S.; Stewart,D. A.; Shea,T. C.; Porcu,P.; Winter,J. N.; Kahl,B. S.; Miller,T. P.; Tubbs,R. R.; Marcellus,D.; Friedberg,J. W.; Barton,K. P.; Mills,G. M.; LeBlanc,M.; Rimsza,L. M.; Forman,S. J.; Fisher,R. I.The New England journal of medicine 2013 ;369(18):1681-1690

Management of diffuse low-grade cerebral gliomas.Prabhu,V.; Khaldi,A.; Barton,K.; Melian,E.; Schneck,M. J.; Primeau,M.; Lee,J. M.Neurology Clinics 2010 ;28(4):1037-1059

Precursor B-cell acute lymphoblastic leukaemia with FAB L3 (i.e., Burkitt's leukaemia/lymphoma) morphology and co-expression of monoclonal surface light chains and Tdt: report of a unique case and review of the literatureHiga,B.; Alkan,S.; Barton,K.; Velankar,M.Pathology 2009 ;41(5):495-498

Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialNand,S.; Godwin,J.; Smith,S.; Barton,K.; Michaelis,L.; Alkan,S.; Veerappan,R.; Rychlik,K.; Germano,E.; Stiff,P.Leukemia & lymphoma 2008 ;49(11):2141-2147

Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation.Levey,S. A.; Bajwa,R. S.; Picken,M. M.; Clark,J. I.; Barton,K.; Leehey,D. J.NDT Plus 2008 ;3( ):154-156

Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy.Kapur,U.; Barton,K.; Fresco,R.; Leehey,D. J.; Picken,M. M.Archives of Pathology & Laboratory Medicine 2007 ;131(9):1368-1372

Recurrent strokes in two patients with POEMS syndrome and Castleman's disease.Garcia,T.; Dafer,R. M.; Hocker,S.; Schneck,M.; Barton,K.; Biller,J.Journal of Stroke & Cerebrovascular Diseases 2007 ;16(6):278-284

Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report.Levitt,M. R.; Benedict,W. J.; Barton,K.; Melian,E.; Gamelli,R. L.; Vandevender,D.; Rosseau,G.; Prabhu,V. C.Journal of Burn Care & Research 2007 ;28(3):524-529

Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challengeNand,S.; Barton,K.Leukemia & lymphoma 2007 ;48(2):215-216

A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.Naeem,M.; Harrison,K.; Barton,K.; Nand,S.; Alkan,S.European journal of haematology 2006 ;76(2):164-166

Transcriptional regulation of CD1D1 by Ets family transcription factorsGeng,Y.; Laslo,P.; Barton,K.; Wang,C. R.Journal of immunology (Baltimore, Md.: 1950) 2005 ;175(2):1022-1029

Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune diseaseWang,D.; John,S. A.; Clements,J. L.; Percy,D. H.; Barton,K. P.; Garrett-Sinha,L. A.International immunology 2005 ;17(9):1179-1191

Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma.Khan,S. B.; Maududi,T.; Barton,K.; Ayers,J.; Alkan,S.British journal of haematology 2004 ;125(2):156-161

Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.Houde,C.; Li,Y.; Song,L.; Barton,K.; Zhang,Q.; Godwin,J.; Nand,S.; Toor,A.; Alkan,S.; Smadja,N. V.; Avet-Loiseau,H.; Lima,C. S.; Miele,L.; Coignet,L. J.Blood 2004 ;104(12):3697-3704

Medical School
  • The Ohio State University College of Medicine and Public Health
  • University of Chicago Hospitals and Clinics, Internal Medicine: General
  • University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology